- Home
- INBK vs ACIU Comparison
INBK vs ACIU Comparison
Compare INBK & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBK
- ACIU
- Stock Information
- Founded
- INBK 1999
- ACIU 2003
- Country
- INBK United States
- ACIU Switzerland
- Employees
- INBK N/A
- ACIU N/A
- Industry
- INBK Major Banks
- ACIU Biotechnology: Pharmaceutical Preparations
- Sector
- INBK Finance
- ACIU Health Care
- Exchange
- INBK Nasdaq
- ACIU Nasdaq
- Market Cap
- INBK 191.0M
- ACIU 213.3M
- IPO Year
- INBK N/A
- ACIU 2016
- Fundamental
- Price
- INBK $24.10
- ACIU $2.45
- Analyst Decision
- INBK Hold
- ACIU Strong Buy
- Analyst Count
- INBK 3
- ACIU 2
- Target Price
- INBK $30.67
- ACIU $10.00
- AVG Volume (30 Days)
- INBK 32.6K
- ACIU 136.3K
- Earning Date
- INBK 10-22-2025
- ACIU 11-04-2025
- Dividend Yield
- INBK 1.01%
- ACIU N/A
- EPS Growth
- INBK N/A
- ACIU N/A
- EPS
- INBK 1.76
- ACIU N/A
- Revenue
- INBK $106,219,000.00
- ACIU $36,362,036.00
- Revenue This Year
- INBK $5.27
- ACIU N/A
- Revenue Next Year
- INBK $27.40
- ACIU $1,022.98
- P/E Ratio
- INBK $13.56
- ACIU N/A
- Revenue Growth
- INBK 4.74
- ACIU 86.71
- 52 Week Low
- INBK $19.54
- ACIU $1.43
- 52 Week High
- INBK $43.27
- ACIU $3.98
- Technical
- Relative Strength Index (RSI)
- INBK 48.34
- ACIU 60.25
- Support Level
- INBK $23.52
- ACIU $2.35
- Resistance Level
- INBK $24.67
- ACIU $2.59
- Average True Range (ATR)
- INBK 0.77
- ACIU 0.14
- MACD
- INBK -0.07
- ACIU 0.03
- Stochastic Oscillator
- INBK 30.47
- ACIU 74.98
About INBK First Internet Bancorp
First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.